CV Sciences (CVSI) Debt to Equity (2013 - 2026)

CV Sciences has disclosed Debt to Equity across 9 years of filings, most recently posting $0.05 for Q1 2026.

• Debt to Equity for Q1 2026 came in at $0.05, down 92.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.05 (down 92.83% YoY), and the FY2025 annual result was $1.12, up 197.83% from the prior year.
• Debt to Equity came in at $0.05 for Q1 2026 at CV Sciences, down from $1.12 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $1.12 in Q4 2025 to a low of $0.05 in Q1 2026.
• The 3-year median for Debt to Equity is $0.65 (2025), against an average of $0.59.
• Across the five-year window, Debt to Equity soared 197.83% in 2025 and plunged 92.83% in 2026, its largest moves.
• CV Sciences' Debt to Equity stood at $0.38 in 2024, then jumped by 197.83% to $1.12 in 2025, then tumbled by 95.72% to $0.05 in 2026.
• The last three Debt to Equity figures came in at $0.05 (Q1 2026), $1.12 (Q4 2025), and $0.62 (Q3 2025), per Business Quant data.